Tekla Capital Management’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-88,102
| Closed | -$384K | – | 197 |
|
|
2021
Q2 | $384K | Hold |
88,102
| – | – | 0.01% | 184 |
|
|
2021
Q1 | $400K | Hold |
88,102
| – | – | 0.01% | 189 |
|
|
2020
Q4 | $506K | Hold |
88,102
| – | – | 0.02% | 191 |
|
|
2020
Q3 | $638K | Hold |
88,102
| – | – | 0.02% | 190 |
|
|
2020
Q2 | $307K | Hold |
88,102
| – | – | 0.01% | 216 |
|
|
2020
Q1 | $130K | Hold |
88,102
| – | – | 0.01% | 208 |
|
|
2019
Q4 | $173K | Hold |
88,102
| – | – | 0.01% | 206 |
|
|
2019
Q3 | $451K | Hold |
88,102
| – | – | 0.02% | 174 |
|
|
2019
Q2 | $631K | Buy |
+88,102
| New | +$631K | 0.03% | 178 |
|
|
2018
Q4 | – | Sell |
-169,962
| Closed | -$1.88M | – | 214 |
|
|
2018
Q3 | $1.88M | Hold |
169,962
| – | – | 0.07% | 160 |
|
|
2018
Q2 | $2.28M | Hold |
169,962
| – | – | 0.09% | 132 |
|
|
2018
Q1 | $2.21M | Sell |
169,962
-40,000
| -19% | -$520K | 0.09% | 131 |
|
|
2017
Q4 | $1.93M | Hold |
209,962
| – | – | 0.07% | 129 |
|
|
2017
Q3 | $1.69M | Buy |
+209,962
| New | +$1.69M | 0.06% | 127 |
|